Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Phone212 218-6347
DescriptionNY VC in early/late stage in performance



610 Fifth Avenue
Suite 305
New York, NY, 10020


Managing Partner
Senior Associate


New Science Ventures

New Science Ventures (NSV) is a New York-based venture capital firm which invests in both early and late stage companies using novel scientific approaches to address significant unmet needs and create order of magnitude improvements in performance. NSV manages over $125 million and has invested in more than 20 companies located in the US, Europe, India and China in the life sciences and information technology sectors.

Recent Milestones


Company Date Round Size Participants
Svelte Medical Systems 3/2014Private Equity$5M3
TigerText 1/2014Series B$21M7
NeXeption 1/2014Series A$21.5M3
Solicore 11/2013Series A$4M7
Svelte Medical Systems 10/2013Private Equity$22M2
Resolve Therapeutics 11/2012Series B$5.8M3
Achronix Semiconductor 8/2012Partial Close$9.84M3
Juventas Therapeutics 7/2012Series B$22.2M8
Vaultive 2/2012Series A$10M3
TigerText 2/2012Series A$8.2M2
Oxyrane UK 11/2011Series D$26.5M3
Resolve Therapeutics 5/2011Series A$2M2
Bioscale 6/2010Series D$25M4
Seahorse Bioscience 3/2010Series D$5M7
BioVex 3/2009Series F$40M7
Seahorse Bioscience 3/2009Series D$6M7
Achronix Semiconductor 10/2008Series B$52M5
TherOx 2/2008Series E$30M3
FlowCardia 8/2007Series C$30M9
Ception Therapeutics 1/2007Series C$63M5
Achronix Semiconductor 1/2007Series A$25.4M4
Light Sciences Oncology 12/2005Series A$67M8



  1. Svelte Medical Systems Raises $5M in Funding ( [edit]
  2. TigerText Raises $21M To Bring Its Secure, Mobile Messaging Platform To The Healthcare Industry ( [edit]
  3. NeXeption Raises $21.5m in Series A to Form Alexar Therapeutics ( [edit]
  4. Solicore holds first close of $4 mln on financing round ( [edit]
  5. Svelte Medical Systems Closes $22M Funding ( [edit]
  6. Resolve Therapeutics Raises $5.8M in Series B Financing ( [edit]
  7. Achronix Semiconductor raises $9.84 million in private offering ( [edit]
  8. Juventas Therapeutics Closes $22.2M Series B Financing ( [edit]
  9. Vaultive keeps your data safe in the cloud, raises $10M ( [edit]
  10. TigerText Completes $8.2m Second Funding ( [edit]
  11. Oxyrane Raises $26.5M in Series D Funding ( [edit]
  12. Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A ( [edit]
  13. BioScale, Inc.: Series D $25M ( [edit]
  14. Seahorse Bioscience, Inc.: Series D $5M ( [edit]
  15. BioVex Raises $40 Million ( [edit]
  16. Seahorse Bioscience lands $6M, buys BioProcessors Corp ( [edit]
  17. Achronix Completes First Close of $52 Million Series B Preferred Stock Financing ( [edit]
  18. TherOx raises $30,000,000 ( [edit]
  19. FlowCardia, Inc. Raises $30 Million In Series C Financing ( [edit]
  20. Ception Therapeutics Raises $63 Million in Series C Financing ( [edit]
  21. Achronix Completes $25.4 Million Series A Preferred Stock Financing ( [edit]
  22. Light Sciences Oncology Completes Second Closing in $67 Million Financing for Late Stage Development of Litx(TM) and Announces Additional Directors; Investors' Additional $32 Million Completes Offering of Series A Preferred ( [edit]
Edit This Page
Last Edited 4/11/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy